THE PROTOTYPICAL PSYCHEDELIC AGENT LSD PRODUCES RAPID ANTIDEPRESSANT EFFECTS VIA 5-HT2B RECEPTOR ACTIVATION
Amel Bouloufa, Sarah Delcourte, Renaud Rovera, Ouria Dkhissi-Benyahya, *Nasser Haddjeri
The International Journal of Neuropsychopharmacology February 12, 2025 DOI: 10.1093/ijnp/pyae059.264 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Preclinical animal study Peer reviewed |
|---|---|
| Population | Rats (anaesthetized for electrophysiology; awake for behavioral tests) |
| Interventions | LSD RS 127445 |
| Topics | LSD Serotonin |
| Key points | LSD suppressed dorsal raphe serotonin neuron firing and produced head twitches, reduced foot-shock-induced ultrasonic vocalizations, and reduced immobility in the forced swimming test; these effects were significantly prevented or counteracted by the 5-HT2B antagonist RS 127445. The authors suggest 5-HT2B receptors play a permissive role in the antidepressant effects of serotonergic psychedelics. |
Abstract
Abstract Background Recent clinical trials reveal that serotonergic psychedelics, including the prototypical hallucinogen lysergic acid diethylamide (LSD), present a promising potential for treating psychiatric disorders, including treatment-resistant depression. LSD is a potent 5-HT receptors ligand endowed with high affinity for most of all 5-HT subtypes and is regularly used as a valuable pharmacological tool to characterize 5-HT1A and 5-HT2A receptor mediations [1]. Notably, a crystal structure of LSD in complex with the human 5-HT2B receptor has been recently described [2]. Aims & Objectives Using both in vivo electrophysiological and behavioral paradigms in rodents, the present work was aimed to evaluate the involvement of the 5-HT2B receptor mediation in the action of LSD, firstly on the spontaneous firing activity of rat dorsal raphe (DRN) 5-HT neurons and secondly in modulating rat head twitch response (hallucinatory-like response), ultrasonic vocalization (anxious-like response) and active coping behaviour (despair-like response). Methods - Extracellular unitary recordings of DRN 5-HT neurons were performed in anaesthetized rat. LSD (i.v.) was injected until cell firing was completely suppressed both after injection of vehicle or the selective 5-HT2B antagonist RS 127445 (i.v.). - Rats were exposed to T1 &T2 sessions of 1 to 4 randomly distributed electric shocks until 22-kHz USV emissions. After 24 h, they received a single shock after vehicle administration (T3 session). After 24 h for the T4 session, they received a single shock after acute vehicle or LSD (i.p.) injection in combination with RS 127445 (i.p.) administration. - Rats were placed in an observation cage and the cumulative number of head twitches (counted during a 30-min period). LSD (i.p.) was injected immediately before the observation while RS 127445 (i,p,) was administered prior to LSD administration. - For the forced swimming test (FST), rats experienced a pre-test session (15 min) followed 24 h later by a test session (5 min). Vehicle or RS 127445 (i.p.) were injected acutely before vehicle or LSD (i.p.) that were administered 5 days before the test session. Results - Acute administration of LSD suppressed totally DRN 5-HT neurons firing rate. Importantly, the selective 5-HT2B receptor antagonist RS 127445 [3] prevented significantly the suppressant effect of LSD. - Acute administration of LSD induced i) an increase of the head twitch response, ii) a suppression of the duration of foot shock– induced USV and iii) a significant decrease of immobility time in the FST. Notably, the latter actions of LSD were significantly counteracted by a prior administration of RS 127445. Conclusion Collectively, the present results suggest for the first time that 5-HT2B receptors play a permissive role in the antidepressant effects of serotonergic psychedelics. References [1]Passie T, et al. (2008) CNS Neurosci Ther. 14(4):295-314. [2]Wacker D, et al. (2017) Cell. 168(3):377-389. [3]Bonhaus, D. et al. (1999) Brit J Pharmacol, 127, 1075–1082.
Comparable studies
Other preclinical and animal studies on LSD, most cited first.